Precision Medicine - G2 Intelligence

Expert Q&A: Trends in Precision Medicine

by Rachel Muenz | May 31, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Inside the Diagnostics Industry-dtet

Christian Olsen, a leader in R&D scientific software, discusses recent developments related to AI and solutions to current precision medicine challenges.

This content is for Paid Members only.
Register

Already a member? Log in here

Tempus Partners to Advance Genomic Cancer Testing

by Glenn S. Demby | Jun 23, 2022 | News, Open Content

The precision medicine company recently announced a pair of strategic alliances aimed at expanding access to new cancer diagnostics.

AACC Guidelines Caution Against Using Serology Tests to Determine COVID-19 Vaccine Efficacy

by Glenn S. Demby | May 10, 2021 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet

...

This content is for Paid Members only.
Register

Already a member? Log in here

Blood Test to Detect Early-Stage Lung Cancer Inches Closer to Reality

by Glenn S. Demby | May 10, 2021 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet

...

This content is for Paid Members only.
Register

Already a member? Log in here

New Genomic Test Can Eliminate Up to One-Third of Medically Unnecessary Prostate Cancer Biopsies

by Glenn S. Demby | Mar 23, 2021 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet

...

This content is for Paid Members only.
Register

Already a member? Log in here

Expert Q&A: Trends in Precision Medicine

Tempus Partners to Advance Genomic Cancer Testing

AACC Guidelines Caution Against Using Serology Tests to Determine COVID-19 Vaccine Efficacy

Blood Test to Detect Early-Stage Lung Cancer Inches Closer to Reality

New Genomic Test Can Eliminate Up to One-Third of Medically Unnecessary Prostate Cancer Biopsies

Log In